[Attachment(s) from arun varghese included below]
Corporate News
· Dishman ties up with California biotech co: Dishman
Pharmaceuticals has entered into a strategic alliance with a
California-based biotech company Codexis. The partnership would let
Dishman use Codexis' proprietary enzymatic bio-catalysis technology
for the manufacturing of building blocks, intermediates and API's for
innovator pharmaceuticals companies. The five-year exclusive agreement
promises to make Dishman the only Indian company to have a high-grade
technology platform in the Indian CRAMS segment. The technology deals
with reduction of chiral compounds in the APIs and provide cheaper,
cleaner, greener processes of manufacturing at a lower cost of
production. It has entered into two separate collaborations in
pharmaceutical manufacturing with Dishman Pharmaceuticals & Chemicals
and AMPAC Fine Chemicals (AFC), a subsidiary of American Pacific
Corporation. Dishman will be a preferred contract manufacturer for
Codexis and will be able to offer the technology to its own customers.
In addition, both companies will work exclusively on certain select
accounts (CRAMs client). Codexis offers a wide selection of enzymes
for the pharmaceuticals synthesis of chiral compounds. With the
majority of today's drugs containing at least one chiral centre, this
technology is directed at the very heart of pharmaceutical
manufacturing.
· Reliance may increase bid for Lyondell: Reliance Industries
may spring a surprise in the tussle to take control of LyondellBasell,
by raising its offer for the Dutch company at the last moment. Today
would be the deadline for a revised proposal. The company was still
working on its offer and may hike it marginally after taking into
account the latest development. The earlier RIL offer had valued the
bankrupt petrochemicals maker at about $13.5 billion. The new offer
would include cash and stock options for shareholders and creditors.
LyondellBasell's unsecured creditors had agreed to settle the dispute
over their claims and decided to support the reorganisation plan of
the present management. The management offered an additional $150
million towards the claims of unsecured creditors, for settling the
dispute. The unsecured creditors, who had part-funded Basell in a
leveraged buyout of the US-based Lyondell in 2007, were supporting the
entry of potential investors such as RIL to rescue it. Unsecured
creditors, including bond holders, are estimated to hold around $3
billion of debt in the company. The reorganisation plan of Lyondell's
management offered to convert $18 billion debt of secured and
unsecured creditors, including bridge loans, into equity. Moreover,
the existing promoters will subscribe to the $3-billion rights issue
of the company to continue management control. After implementing the
plan, the chemical giant would value around $21 billion. Once Lyondell
emerges out of Chapter 11 (a legal provision where a company gets
breathing space to restructure itself as an alternative to formal
bankruptcy) ain the US, RIL would prefer to have a controlling stake
in the company by buying out a part of the shareholders' equity and
subsequently subscribing to fresh shares. It had been building a
financial war chest in the past six months by selling its treasury
shares, eyeing "global opportunities". While it has a cash reserve of
over Rs.9000 crore through the sale of its treasury stock, it is in a
position to raise another Rs.13000 crore by selling the remaining
treasury shares.
· BHEL to ink pact with Sheffield Forgemasters for tech
transfer: BHEL t will sign a technology transfer pact with UK-based
Sheffield Forgemasters next week to upgrade manufacturing of castings
and forgings. It will be signing a collaboration pact with Sheffield
Forgemasters next week. This will enable it to use their technology
for upgrading the manufacturing of castings and forgings at our
Haridwar plant.
· Adani to invest Rs.10000 crore on Orissa port: Adani Group
has shown interest in setting up a port in Orissa with an investment
of Rs.10000 crore. The Adani Group has given this proposal to set up a
port. The state government is examining the proposal," said Satyabrat
Sahu, transport and commerce secretary of Orissa. Once the proposed
port comes up it would be named the Adani-Kalinga Port, the group
plans to develop the port in two phases near Paradip in Jagatsinghpur
district, three km from the proposed Posco India port. The group plans
to invest Rs.5000 crore in each of the two phases. The proposed port
would have 12 berths and would be completed by 2015-16. The proposed
all weather port will have a capacity of 100 million tonnes.
-
--
Share reports. Share knowledge. Contribute and Gain. Together we grow BETTER and BIGGER. Share your reports with everyone. Take, and help others take informed decisions.
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
We understand that reports are copyrighted materials of their respective authors/firms, and we pay sincere tribute to their efforts. We don't copy, we share.
Corporate News
· Dishman ties up with California biotech co: Dishman
Pharmaceuticals has entered into a strategic alliance with a
California-based biotech company Codexis. The partnership would let
Dishman use Codexis' proprietary enzymatic bio-catalysis technology
for the manufacturing of building blocks, intermediates and API's for
innovator pharmaceuticals companies. The five-year exclusive agreement
promises to make Dishman the only Indian company to have a high-grade
technology platform in the Indian CRAMS segment. The technology deals
with reduction of chiral compounds in the APIs and provide cheaper,
cleaner, greener processes of manufacturing at a lower cost of
production. It has entered into two separate collaborations in
pharmaceutical manufacturing with Dishman Pharmaceuticals & Chemicals
and AMPAC Fine Chemicals (AFC), a subsidiary of American Pacific
Corporation. Dishman will be a preferred contract manufacturer for
Codexis and will be able to offer the technology to its own customers.
In addition, both companies will work exclusively on certain select
accounts (CRAMs client). Codexis offers a wide selection of enzymes
for the pharmaceuticals synthesis of chiral compounds. With the
majority of today's drugs containing at least one chiral centre, this
technology is directed at the very heart of pharmaceutical
manufacturing.
· Reliance may increase bid for Lyondell: Reliance Industries
may spring a surprise in the tussle to take control of LyondellBasell,
by raising its offer for the Dutch company at the last moment. Today
would be the deadline for a revised proposal. The company was still
working on its offer and may hike it marginally after taking into
account the latest development. The earlier RIL offer had valued the
bankrupt petrochemicals maker at about $13.5 billion. The new offer
would include cash and stock options for shareholders and creditors.
LyondellBasell's unsecured creditors had agreed to settle the dispute
over their claims and decided to support the reorganisation plan of
the present management. The management offered an additional $150
million towards the claims of unsecured creditors, for settling the
dispute. The unsecured creditors, who had part-funded Basell in a
leveraged buyout of the US-based Lyondell in 2007, were supporting the
entry of potential investors such as RIL to rescue it. Unsecured
creditors, including bond holders, are estimated to hold around $3
billion of debt in the company. The reorganisation plan of Lyondell's
management offered to convert $18 billion debt of secured and
unsecured creditors, including bridge loans, into equity. Moreover,
the existing promoters will subscribe to the $3-billion rights issue
of the company to continue management control. After implementing the
plan, the chemical giant would value around $21 billion. Once Lyondell
emerges out of Chapter 11 (a legal provision where a company gets
breathing space to restructure itself as an alternative to formal
bankruptcy) ain the US, RIL would prefer to have a controlling stake
in the company by buying out a part of the shareholders' equity and
subsequently subscribing to fresh shares. It had been building a
financial war chest in the past six months by selling its treasury
shares, eyeing "global opportunities". While it has a cash reserve of
over Rs.9000 crore through the sale of its treasury stock, it is in a
position to raise another Rs.13000 crore by selling the remaining
treasury shares.
· BHEL to ink pact with Sheffield Forgemasters for tech
transfer: BHEL t will sign a technology transfer pact with UK-based
Sheffield Forgemasters next week to upgrade manufacturing of castings
and forgings. It will be signing a collaboration pact with Sheffield
Forgemasters next week. This will enable it to use their technology
for upgrading the manufacturing of castings and forgings at our
Haridwar plant.
· Adani to invest Rs.10000 crore on Orissa port: Adani Group
has shown interest in setting up a port in Orissa with an investment
of Rs.10000 crore. The Adani Group has given this proposal to set up a
port. The state government is examining the proposal," said Satyabrat
Sahu, transport and commerce secretary of Orissa. Once the proposed
port comes up it would be named the Adani-Kalinga Port, the group
plans to develop the port in two phases near Paradip in Jagatsinghpur
district, three km from the proposed Posco India port. The group plans
to invest Rs.5000 crore in each of the two phases. The proposed port
would have 12 berths and would be completed by 2015-16. The proposed
all weather port will have a capacity of 100 million tonnes.
-
--
Share reports. Share knowledge. Contribute and Gain. Together we grow BETTER and BIGGER. Share your reports with everyone. Take, and help others take informed decisions.
~~~~~~~~~~~~
We understand that reports are copyrighted materials of their respective authors/firms, and we pay sincere tribute to their efforts. We don't copy, we share.
__._,_.___
Attachment(s) from arun varghese
1 of 1 File(s)
.
__,_._,___
No comments:
Post a Comment